Pathophysiological and pharmacological implications of elucidating the molecular bases of the interaction between HBV and the bile acid transporter NTCP
Main Authors: | Marta R. Romero, Maria J. Monte, Jose J.G. Marin, Ph.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2015-01-01
|
Series: | Annals of Hepatology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268119308142 |
Similar Items
-
Innovative HBV Animal Models Based on the Entry Receptor NTCP
by: Jochen M. Wettengel, et al.
Published: (2020-07-01) -
Spinoculation Enhances HBV Infection in NTCP-Reconstituted Hepatocytes.
by: Ran Yan, et al.
Published: (2015-01-01) -
Elevated NTCP expression by an iPSC-derived human hepatocyte maintenance medium enhances HBV infection in NTCP-reconstituted HepG2 cells
by: Xinlei Li, et al.
Published: (2021-07-01) -
The role of HBV spliced variants in HBV in vitro infection in HepG2-NTCP-C4 cell line
by: Po-Wen Wang, et al.
Published: (2018) -
Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability
by: Fangji Yang, et al.
Published: (2019-03-01)